3M launches two new respirators
These two respirators – 3M Particulate Respirator 8612F and 3M Particulate Respirator 8670F – are said to be unique because they are the first to receive clearance by
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.